Ortho-Clinical signs $75 million deal with AmeriNet:
This article was originally published in Clinica
Ortho-Clinical Diagnostics has signed a three-year purchasing agreement with AmeriNet, which OCD claims is worth an estimated $75 million. Under the agreement AmeriNet members will get preferred pricing on all Vitros brand clinical chemistry and immunoassay instruments, reagents, consumables and accessories. OCD is a Raritan, New Jersey-based subsidiary of Johnson & Johnson. AmeriNet has a membership of more than 7,200 healthcare facilities across the US.
You may also be interested in...
Operation Warp Speed will hold back initial shipments to ensure two-dose regimens can be completed; 15 December is ‘chalk’ target date for emergency authorization of Pfizer vaccine, OWS’ Gustave Perna says, calling it only a projection that does not impinge on FDA authority. Sending only half shipments also eases burden on cold shortage capacity at state and local level, he says.
CMS acknowledges stakeholders may need more details about the plan before it is finalized and a delay will give the agency more time to ‘consider the issue.’
Private Company Edition: Venture capital financings didn’t take a break during Thanksgiving week. In addition to the $800m Resilience raised to fund manufacturing services, SomaLogic closed a $121m series A round to fund its proteomic tools for drug discovery and diagnostics development.